Alyssa Kipke

Dr. Alyssa Kipke


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 September 2022 in Hematology Reports
Verified
Journal Article
Open access
PDF file
BWBrandon Travis Wiggins
Brandon Travis Wiggins
DRDaniel Ramirez
Daniel Ramirez
DTDaniel Paul Taylor
Daniel Paul Taylor
WRWilliam Reichardt
William Reichardt
AKAlyssa Kipke
Alyssa Kipke
MMMark Minaudo
Mark Minaudo
Liver cirrhosis is commonly associated with coagulopathies, typically demonstrated by elevated prothrombin time, international normalized ratio, and partial thromboplastin time. In the setting of bleeding related to coagulopathies, oftentimes physicians try to reverse coagulopathy through a variety of methods including the use of vitamin K and fresh frozen plasma. Rarely, attempts at reversing coagulopathy are unsuccessful due to severe disease or factor inhibitors. The treatment of acquired factor V inhibitors is primarily performed through immunosuppression and supportive care for the initial bleeding episode. Early detection and treatment of factor V inhibition is challenging in a setting of underlying cirrhosis-related coagulopathy.